← FDA DRUG APPROVALS

FDA ANDA · ANDA078512

ATENOLOL

Sponsor: AUROBINDO PHARMA

APPLICATION
ANDA078512
TYPE
ANDA
ORIGINAL APPROVAL
2007-10-31
LATEST ACTION
2024-03-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ATENOLOLPrescription
ATENOLOL 50MG · TABLET · ORAL
ATENOLOLPrescription
ATENOLOL 100MG · TABLET · ORAL
ATENOLOLPrescription
ATENOLOL 25MG · TABLET · ORAL

Approval history

2024-03-29Labeling · Supplement 18 · standardAP
2015-05-27Labeling · Supplement 7 · standardAP
2012-01-17Manufacturing (CMC) · Supplement 4AP
2011-10-18Labeling · Supplement 5AP
2009-09-02Labeling · Supplement 2AP
2007-10-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →